Literature DB >> 22074065

Characteristic of cognitive decline in Parkinson's disease: a 1-year follow-up.

Audrey McKinlay1, Randolph C Grace.   

Abstract

The aim of this study was to track the evolution of cognitive decline in Parkinson's disease (PD) patients 1 year after baseline testing. Thirty-three PD patients, divided according to three previously determined subgroups based on their initial cognitive performance, and a healthy comparison group were reassessed after a 1-year interval. Participants were assessed in the following five domains: Executive Function, Problem Solving, Working Memory/Attention, Memory, and Visuospatial Ability. The PD groups differed on the domains of Executive Function, Problem Solving, and Working Memory, with the most severe deficits being evident for the group that had previously shown the greatest level of impairment. Increased cognitive problems were also associated with decreased functioning in activities of daily living. The most severely impaired group had evidence of global cognitive decline, possibly reflecting a stage of preclinical dementia.

Entities:  

Mesh:

Year:  2011        PMID: 22074065     DOI: 10.1080/09084282.2011.595453

Source DB:  PubMed          Journal:  Appl Neuropsychol        ISSN: 0908-4282


  2 in total

1.  Effects of the adenosine A2A antagonist istradefylline on cognitive performance in rats with a 6-OHDA lesion in prefrontal cortex.

Authors:  Takako Kadowaki Horita; Minoru Kobayashi; Akihisa Mori; Peter Jenner; Tomoyuki Kanda
Journal:  Psychopharmacology (Berl)       Date:  2013-06-10       Impact factor: 4.530

Review 2.  Bias Investigation in Artificial Intelligence Systems for Early Detection of Parkinson's Disease: A Narrative Review.

Authors:  Sudip Paul; Maheshrao Maindarkar; Sanjay Saxena; Luca Saba; Monika Turk; Manudeep Kalra; Padukode R Krishnan; Jasjit S Suri
Journal:  Diagnostics (Basel)       Date:  2022-01-11
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.